Evidence map›Paper›PMID 35415721›Full record

ArticleNature synthesis2022

Combining chemistry and protein engineering for new-to-nature biocatalysis.

David C Miller, Soumitra V Athavale, Frances H Arnold

Abstract read
In one paragraph

Article in Nature synthesis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Reticular Chemistry: A Versatile Platform for Engineering Heterogenous Biocatalysts.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  13. New-to-Nature Photoenzymatic Catalysis.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  14. Glycosylated cannabinoids inProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  15. Article
  16. Synzymes: The Future of Modern Enzyme Engineering.Applied biochemistry and biotechnology · 2025
    Review
  17. Review
  18. Article
  19. Designing Enzymatic Reactivity with an Expanded Palette.Chembiochem : a European journal of chemical biology · 2025
    Review
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David C MillerDivision of Chemistry and Chemical Engineering, California Institute of Technology Pasadena, California, 91125.
Soumitra V AthavaleDivision of Chemistry and Chemical Engineering, California Institute of Technology Pasadena, California, 91125.
Frances H ArnoldDivision of Chemistry and Chemical Engineering, California Institute of Technology Pasadena, California, 91125.

Funding

Biocatalytic C-H Activation for Enantioselective Carbon-Carbon Bond FormationF32GM128247 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI MILLER, DAVID C. · 2018 to 2021
$219k
NIGMS NIH HHS F32 GM128247
6 · The paper itself

Abstract

Biocatalysis, the application of enzymes to solve synthetic problems of human import, has blossomed into a powerful technology for chemical innovation. In the past decade, a threefold partnership, where nature provides blueprints for enzymatic catalysis, chemists introduce innovative activity modes with abiological substrates, and protein engineers develop new tools and algorithms to tune and improve enzymatic function, has unveiled the frontier of

Identifiers

PMID35415721
PMCPMC8995090

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.